文献速递肝病

基于弹性成像的墨西哥裔美国人队列中肝纤维化高患病率的人群研究

High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-11

该研究在2015至2017年对德克萨斯州南部406名墨西哥裔美国人进行pSWE检测,最终分析347人,显著纤维化(F2-F4)患病率为13.8%,其中88.1%无病毒性肝炎或大量饮酒证据,纤维化主要归因于代谢性疾病。

要点

  • 墨西哥裔美国人显著纤维化患病率为13.8%。
  • 多数纤维化患者(88.1%)无病毒性肝炎或大量饮酒证据。
  • 纤维化主要归因于代谢性疾病,而非单纯脂肪变。

核心结论

  • 墨西哥裔美国人肝纤维化患病率高于欧洲和亚洲人群,主要归因于代谢性疾病。

研究设计与样本

  • 基于人群的队列研究,纳入德克萨斯州南部Cameron County Hispanic Cohort中406名参与者,2015至2017年由2名操作者进行pSWE检测,最终分析347人。

主要发现

  • 显著纤维化(F2-F4,中位硬度>1.34 m/s)患病率为13.8%。
  • 42名显著纤维化者中37人(88.1%)无病毒性肝炎或大量饮酒证据。
  • 肝酶水平与纤维化和单纯脂肪变均相关。
  • 代谢健康指标(胰岛素抵抗、甘油三酯和胆固醇)与单纯脂肪变显著相关。
  • 纤维化(而非单纯脂肪变)与血浆抗HCV抗体显著相关(OR 18.9;P=0.0138),与血小板减少非显著相关(每50×10³/μL OR 0.8;95%CI 0.5-1.1)。

关键数值与推荐

  • 显著纤维化定义为中位硬度>1.34 m/s。
  • 脂肪变通过超声判定。

局限性

  • 59名参与者因pSWE结果不可靠或超声结果不确定被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hepatic fibrosis is a primary risk factor for cirrhosis and hepatocellular carcinoma, which affect a disproportionate number of Hispanics in the United States. We aimed to determine the prevalence of significant fibrosis, measured by point shear-wave elastography (pSWE), and determine characteristics of hepatic fibrosis and simple steatosis in a population-based study of Mexican American Hispanics in south Texas. METHODS: Liver stiffness was measured by pSWE, performed by 2 separate operators, for 406 participants in the Cameron County Hispanic Cohort from 2015 through 2017. Significant fibrosis (F2-F4) was defined as median stiffness > 1.34 m/s. Steatosis was determined by ultrasound. All participants underwent a clinical examination that included a comprehensive laboratory analysis and standardized interview about their medical and social history. We calculated weighted prevalence of fibrosis and determined clinical and demographic associations with significant fibrosis (with or without steatosis) and simple steatosis with no/minimal fibrosis using multinomial logistic regression. RESULTS: Fifty-nine participants were excluded due to unreliable pSWE findings or inconclusive ultrasound results, for a final analysis of 347 participants. The prevalence of significant fibrosis was 13.8%; most of these participants (37/42, 88.1%) had no evidence of viral hepatitis or heavy drinking. Levels of liver enzymes were associated with fibrosis and simple steatosis. Indicators of metabolic health (insulin resistance, triglycerides, and cholesterol) were significantly associated with simple steatosis. Fibrosis, but not simple steatosis, was significantly associated with of antibodies against HCV in plasma (odds ratio, 18.9; P = .0138) and non-significantly associated with reduced platelet count (odds ratio, 0.8 per 50x103/μL; 95% CI, 0.5-1.1). Multivariable analyses, as well as sensitivity analyses removing F4 fibrosis and viral or alcoholic etiologies, confirmed our results. CONCLUSION: We estimated the prevalence of fibrosis in a large population of Mexican American Hispanics using pSWE measurements. We found Mexican American Hispanics to have a higher prevalence of fibrosis compared to European and Asian populations, primarily attributable to metabolic disease.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Watt GP, Lee M, Pan JJ, et al. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans. Clin Gastroenterol Hepatol. 2018. PMID: 29902644. doi:10.1016/j.cgh.2018.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。